Universe Pharmaceuticals Inc banner
U

Universe Pharmaceuticals Inc
NASDAQ:UPC

Watchlist Manager
Universe Pharmaceuticals Inc
NASDAQ:UPC
Watchlist
Price: 2.86 USD -1.72% Market Closed
Market Cap: $1.6m

Income Statement

Earnings Waterfall
Universe Pharmaceuticals Inc

Income Statement
Universe Pharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Sep-2020 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024 Sep-2024 Mar-2025 Sep-2025
Revenue
Interest Expense
0
0
0
0
0
0
0
0
0
0
Revenue
31
N/A
48
+56%
72
+50%
40
-44%
34
-14%
32
-6%
27
-17%
23
-14%
19
-16%
18
-7%
Gross Profit
Cost of Revenue
(17)
(23)
(33)
(18)
(20)
(22)
(19)
(17)
(13)
(12)
Gross Profit
14
N/A
25
+80%
39
+54%
22
-44%
14
-35%
10
-28%
8
-27%
6
-20%
6
-3%
6
+7%
Operating Income
Operating Expenses
(4)
(12)
(23)
(29)
(24)
(14)
(13)
(14)
(14)
(9)
Selling, General & Administrative
(3)
(6)
(17)
(22)
(14)
(9)
(11)
(11)
(11)
(8)
Research & Development
(1)
(5)
(6)
(8)
(10)
(5)
(3)
(3)
(3)
(0)
Depreciation & Amortization
(0)
(0)
0
(0)
0
(0)
(0)
(0)
0
(0)
Operating Income
10
N/A
14
+33%
16
+20%
(7)
N/A
(10)
-34%
(4)
+60%
(6)
-48%
(8)
-37%
(9)
-7%
(3)
+66%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
(0)
(0)
(0)
(8)
(0)
7
(0)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
(0)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
Total Other Income
(0)
0
1
(0)
(1)
(0)
(3)
0
2
(0)
Pre-Tax Income
10
N/A
14
+35%
17
+24%
(8)
N/A
(11)
-38%
(4)
+61%
(17)
-293%
(8)
+52%
1
N/A
(4)
N/A
Net Income
Tax Provision
(3)
(2)
(4)
(1)
(0)
(2)
(2)
(1)
0
0
Income from Continuing Operations
8
11
13
(9)
(11)
(7)
(19)
(9)
1
(4)
Net Income (Common)
8
N/A
11
+50%
13
+15%
(9)
N/A
(11)
-28%
(7)
+41%
(19)
-188%
(9)
+54%
1
N/A
(4)
N/A
EPS (Diluted)
32.39
N/A
53.67
+66%
53.99
+1%
-1 447.01
N/A
-46.3
+97%
-1 089.57
-2 253%
-3 120.3
-186%
-626.96
+80%
3.13
N/A
-8.06
N/A